Results 171 to 180 of about 6,753 (222)

Comparing venous wall effects using the empty vein ablation technique with VELEX catheter, endovenous laser ablation and foam sclerotherapy in an animal model. [PDF]

J Vasc Surg Venous Lymphat Disord
Salerno M, Bissacco D, Chi YW, Narayanan S, Addis A, Martelli F, Zaccagnini G, Aloi TL, Nano G, Gianesini S, Righini P.   +10 more
europepmc   +1 more source

Steatotic Liver Disease: A Key Related Risk Factor in the Emergence of Metabolic Syndrome‐Related Disorders

Hepatology Research, Volume 56, Issue 4, Page 436-445, April 2026.
It is speculated that the onset of obesity‐related diseases follows the sequence of obesity → SLD → MetS‐related diseases. In this study, the contribution of SLD to each MetS‐related disease was large for T2D and hypertension and SLD contributed to the onset and new onset of the disease by the 7‐year follow‐up.
Yoshihiro Kamada, Makoto Fujii, Hitoshi Nishizawa, Shiro Fukuda, Makoto Yamada, Iichiro Shimomura, Eiji Miyoshi   +6 more
wiley   +1 more source

Investigation of the sclerosing effect of increasing doses of polidocanol on pulmonary vessels: Experimental study. [PDF]

Medicine (Baltimore)
Zorlu D, Özdemir I, Bayar Muluk N, Güngör E, Yilmaz E, Cingi C.   +5 more
europepmc   +1 more source

Prevalence and risk factors for metabolic dysfunction–associated steatotic liver disease in Sweden: Insights from the SCAPIS cohort

Journal of Internal Medicine, Volume 299, Issue 4, Page 481-501, April 2026.
Abstract Background and Aims Metabolic dysfunction–associated steatotic liver disease (MASLD) is the most common chronic liver disease globally, but its prevalence and severity remain poorly characterized in the general population. Our aim was to estimate the prevalence of MASLD and the risk of advanced fibrosis in a large Swedish general population ...
Oumarou Nabi, Jonas Spaak, Göran Bergström, Gunnar Engström, Carl Johan Östgren, Andrei Malinovschi, Joel Kullberg, Anders Blomberg, Tomas Jernberg, Daniel P. Andersson, Hannes Hagström   +10 more
wiley   +1 more source

Exploring causal links between autoimmune liver diseases, chronic hepatitis C, and thyroid disorders: Evidence from NHANES and GWAS studies. [PDF]

Medicine (Baltimore)
Nie Q, Jiang Y, Liang Q, Li M, Huang C, Yuan Y, Qiu T, Ma X, Li J.   +8 more
europepmc   +1 more source

Liver transplantation in the cyclosporin era [PDF]

, 1983
Esquivel, CO, Gordon, RD, Iwatsuki, S, Shaw, BW, Starzl, TE   +4 more
core  

Graft and Patient Survival After Liver Transplantation for Primary Sclerosing Cholangitis: A French National Cohort Study

Liver International, Volume 46, Issue 4, April 2026.
ABSTRACT Background A significant proportion of patients presenting a primary sclerosing cholangitis (PSC) will require liver transplantation (LT). The present study aimed to investigate graft loss and patient death in a large cohort of patients. Methods We conducted a nationwide multicenter retrospective study including all adult patients transplanted
Florian Veyre, Claire Francoz, Domitille Erard, Eleonora DeMartin, Laure Elkrief, Camille Besch, Olivier Boillot, Filomena Conti, Sébastien Dharancy, Christophe Duvoux, Jean Gugenheim, Jean Hardwigsen, Marie‐Noëlle Hilleret, Vincent Leroy, Isabelle Ollivier‐Hourmand, Marilyne Gratien, Pauline Houssel‐Debry, Nassim Kamar, Olivier Roux, Jean‐Baptiste Hiriart, Marie Irles‐Depe, Sophie Pellegrin, François Durand, Georges‐Philippe Pageaux, Stéphanie Faure, Audrey Coilly, Sylvie Radenne, Faouzi Saliba, Didier Samuel, Claire Vanlemmens, Marianne Latournerie, Karim Boudjema, Ephrem Salamé, Olivier Chazouillères, Christophe Corpechot, Jérôme Dumortier   +35 more
wiley   +1 more source

Comparison of bleomycin polidocanol foam versus absolute ethanol for sclerotherapy of venous malformations. [PDF]

J Vasc Surg Venous Lymphat Disord
Lai J, Xu Z, Chen H, Hu L, Lin X, Yang X.   +5 more
europepmc   +1 more source

Early Prediction of Hepatic Decompensation in Cirrhosis Using Optimised XGBoost Models at the Initial Outpatient Hepatology Visit

Liver International, Volume 46, Issue 4, April 2026.
ABSTRACT Background and Aims Hepatic decompensation represents a critical transition in cirrhosis, leading to increased morbidity, mortality and healthcare utilisation. Identifying patients at risk of decompensation remains a clinical challenge. We aimed to develop and validate XGBoost models to predict hepatic decompensation at multiple time points ...
Micah Grubert Van Iderstine, Sem Perez, Gregory S. Jackson, Tyler Szun, Caelan Stephanson, Megan Weisshaar, Gerald Y. Minuk, Nabiha Faisal   +7 more
wiley   +1 more source

Clinical rationale behind glucose-sparing strategies in peritoneal dialysis: a narrative review. [PDF]

BMC Nephrol
Lindholm B, Barbari A, Allen J, Dufour I, Fraser D, Heider A, Kazancioglu R, Lichodziejewska-Niemierko M, Malho-Guedes A, Neri L, Parikova A, Quevedo-Reina JC, Santana-Quintana A, Udayaraj U.   +13 more
europepmc   +1 more source